Driver mutations in <i>TP53</i> are ubiquitous in high grade serous carcinoma of the ovaryAhmed A. Ahmed, James D. Brenton, Dariush Etemadmoghadam et al.|The Journal of Pathology|2010Cited by 836
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genesSally M. Hunter, Ian Campbell, Michael S. Anglesio et al.|Oncotarget|2015Cited by 201
Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential TumorsMichael S. Anglesio, David D.L. Bowtell, Jeremy M. Arnold et al.|Molecular Cancer Research|2008Cited by 130
Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <i>TP53</i> -Mutant Tumors and Identifies <i>NRAS</i> as an Oncogenic DriverCatherine Emmanuel, Anna DeFazio, Yoke-Eng Chiew et al.|Clinical Cancer Research|2014Cited by 119
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S. Meagher, Raghwa Sharma, Anthony J. Swerdlow et al.|Modern Pathology|2019Cited by 104